Cancers 2010, 2(2), 1198-1220; doi:10.3390/cancers2021198
Review

Inflammatory Genetic Markers of Prostate Cancer Risk

1 Cancer Genetics Group, Children’s Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, University of New South Wales, PO Box 81, Randwick, NSW 2031, Australia 2 University of New South Wales, Kensington Campus, Sydney, NSW 2052, Australia
* Author to whom correspondence should be addressed.
Received: 6 May 2010; in revised form: 24 May 2010 / Accepted: 1 June 2010 / Published: 8 June 2010
(This article belongs to the Special Issue Biomarkers: Oncology Studies)
PDF Full-text Download PDF Full-Text [289 KB, uploaded 8 June 2010 13:25 CEST]
Abstract: Prostate cancer is the most common cancer in Western society males, with incidence rates predicted to rise with global aging. Etiology of prostate cancer is however poorly understood, while current diagnostic tools can be invasive (digital rectal exam or biopsy) and/or lack specificity for the disease (prostate-specific antigen (PSA) testing). Substantial histological, epidemiological and molecular genetic evidence indicates that inflammation is important in prostate cancer pathogenesis. In this review, we summarize the current status of inflammatory genetic markers influencing susceptibility to prostate cancer. The focus will be on inflammatory cytokines regulating T-helper cell and chemokine homeostasis, together with the Toll-like receptors as key players in the host innate immune system. Although association studies indicating a genetic basis for prostate cancer are presently limited mainly due to lack of replication, larger and more ethnically and clinically defined study populations may help elucidate the true contribution of inflammatory gene variants to prostate cancer risk.
Keywords: prostate cancer; inflammation; Toll like receptor (TLR); cytokine; chemokine; gene variant; inherited susceptibility

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Tindall, E.A.; Hayes, V.M.; Petersen, D.C. Inflammatory Genetic Markers of Prostate Cancer Risk. Cancers 2010, 2, 1198-1220.

AMA Style

Tindall EA, Hayes VM, Petersen DC. Inflammatory Genetic Markers of Prostate Cancer Risk. Cancers. 2010; 2(2):1198-1220.

Chicago/Turabian Style

Tindall, Elizabeth A.; Hayes, Vanessa M.; Petersen, Desiree C. 2010. "Inflammatory Genetic Markers of Prostate Cancer Risk." Cancers 2, no. 2: 1198-1220.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert